Table 1.

Characteristics of the patient cohort investigated in this study

	Stable		No growth		Gram-positive		Gram-negative
	no.	%	no.	%	no.	%	no.	%
Age, yr, mean ± SEM	70.1 ± 2.2		63.8 ± 2.9		65.9 ± 2.1		68.6 ± 3.3
18–40	1	4.2	1	5.3	4	8.5	1	5.9
40–50	1	4.2	1	5.3	3	6.4	0	0
50–60	0	0	1	5.3	6	12.8	3	17.7
60–70	8	33.3	11	57.9	14	29.8	3	17.7
70–80	10	41.7	3	15.8	12	25.5	8	47.1
≥80	4	16.7	2	10.5	8	17.0	2	11.8
Sex
Male	18	75	11	57.9	32	68.1	9	52.9
Female	6	25	8	42.1	15	31.9	8	47.1
Days on PD, mean ± SEM	1165.1 ± 186.5		638.8 ± 163.5		1022.9 ± 144.2		768.5 ± 245.8
0–30	0	0	3	15.8	1	2.1	0	0
30–360	1	4.2	4	21.1	15	31.9	9	52.9
360–720	9	37.5	6	31.6	8	17.0	3	17.7
720–1800	8	33.3	4	21.1	16	34.0	3	17.7
1800–3600	5	20.8	2	10.5	6	12.8	1	5.9
≥3600	1	4.2	0	0	1	2.1	1	5.9
Hypertension
Yes	12	50	2	10.5	14	29.8	7	41.2
No	12	50	17	89.5	33	70.2	10	58.8
Diabetes
Yes	7	29.2	6	31.6	13	27.7	7	41.2
No	17	70.8	13	68.4	34	72.3	10	58.8
Technique failure
Days 0–14	N/A		1	5.3	2	4.3	2	11.8
Days 14–30	N/A		2	10.5	3	6.5	2	11.8
Days 30–90	N/A		1	5.3	6	12.9	4	23.5
Mortality
Days 0–14	N/A		1	5.3	0	0	1	5.9
Days 14–90	N/A		1	5.3	0	0	1	5.9

N/A, not available; PD, peritoneal dialysis.